Peri-Procedural Safety of GLP-1 Receptor Agonists in Elective Endoscopy: A Multicenter Retrospective Cohort Study

<b>Background and Aims</b>: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) delay gastric emptying, raising concerns about periprocedural safety in elective endoscopy. We aimed to evaluate the association between pre-procedural GLP-1 RA use and post-procedural complications such as aspiration pneumonia. <b>Methods</b>: In this retrospective cohort study, adults (18-89 years) undergoing outpatient esophagogastroduodenoscopy or colonoscopy within the HCA Healthcare network from 1 July 2021 to 31 March 2024 were identified. Patients were classified as GLP-1 RA users (<i>n</i> = 953) or non-users (<i>n</i> = 3289) based on home medication records. Primary outcomes included aspiration, post-procedural oxygen requirement, hypotension, hospitalization, ICU admission, length of stay, and all-cause inpatient mortality. Multivariable logistic and negative-binomial regression models, incorporating an interaction term for anesthesia type, were adjusted for age, sex, body mass index, ASA class, and key comorbidities. <b>Results</b>: No aspiration events were reported in either group. GLP-1 RA use was associated with lower odds of post-procedural oxygen requirement (OR 0.43, 95% CI 0.25-0.76), hospitalization (OR 0.73, 95% CI 0.39-1.36), and mortality (0.1 vs. 0.9%, <i>p</i> = 0.014), and a shorter hospital stay (IRR 0.54, 95% CI 0.40-0.71). Rates of hypotension and ICU admission were similar between both groups. In anesthesia-stratified analysis among GLP-1 RA users, those receiving MAC/MS had higher odds of hospitalization compared with GA (OR 1.87, 95% CI 1.23-2.85, <i>p</i> = 0.003), whereas other outcomes were not significant. <b>Conclusions</b>: Pre-procedural GLP-1 RA therapy was not associated with increased peri-procedural complications. Although hospitalization was more frequent with MAC/MS, this difference did not extend to other clinically significant outcomes. Further prospective studies are needed to clarify the clinical implications of anesthesia choice.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2025-08-30
DOI
https://doi.org/10.3390/jcm14176147
Primary Topic
Gastric Cancer Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Peri-Procedural Safety of GLP-1 Receptor Agonists in Elective Endoscopy: A Multicenter Retrospective Cohort Study

Tony S. Brar, Hussein A Noureldine, Mohammad Abuassi, Yaseen Perbtani et al.
Journal of Clinical Medicine
Gastric Cancer Management and Outcomes
article

Peri-Procedural Safety of GLP-1 Receptor Agonists in Elective Endoscopy: A Multicenter Retrospective Cohort Study

Tony S. Brar, Hussein A Noureldine, Mohammad Abuassi, Yaseen Perbtani, Raghav Bassi, Harsimran Kalsi, Kobina Essilfie‐Quaye, R. Meadows, Carson Creamer
article en

Abstract

<b>Background and Aims</b>: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) delay gastric emptying, raising concerns about periprocedural safety in elective endoscopy. We aimed to evaluate the association between pre-procedural GLP-1 RA use and post-procedural complications such as aspiration pneumonia. <b>Methods</b>: In this retrospective cohort study, adults (18-89 years) undergoing outpatient esophagogastroduodenoscopy or colonoscopy within the HCA Healthcare network from 1 July 2021 to 31 March 2024 were identified. Patients were classified as GLP-1 RA users (<i>n</i> = 953) or non-users (<i>n</i> = 3289) based on home medication records. Primary outcomes included aspiration, post-procedural oxygen requirement, hypotension, hospitalization, ICU admission, length of stay, and all-cause inpatient mortality. Multivariable logistic and negative-binomial regression models, incorporating an interaction term for anesthesia type, were adjusted for age, sex, body mass index, ASA class, and key comorbidities. <b>Results</b>: No aspiration events were reported in either group. GLP-1 RA use was associated with lower odds of post-procedural oxygen requirement (OR 0.43, 95% CI 0.25-0.76), hospitalization (OR 0.73, 95% CI 0.39-1.36), and mortality (0.1 vs. 0.9%, <i>p</i> = 0.014), and a shorter hospital stay (IRR 0.54, 95% CI 0.40-0.71). Rates of hypotension and ICU admission were similar between both groups. In anesthesia-stratified analysis among GLP-1 RA users, those receiving MAC/MS had higher odds of hospitalization compared with GA (OR 1.87, 95% CI 1.23-2.85, <i>p</i> = 0.003), whereas other outcomes were not significant. <b>Conclusions</b>: Pre-procedural GLP-1 RA therapy was not associated with increased peri-procedural complications. Although hospitalization was more frequent with MAC/MS, this difference did not extend to other clinically significant outcomes. Further prospective studies are needed to clarify the clinical implications of anesthesia choice.

Journal of Clinical MedicineVol. 14(17)
University of Central Florida (US), UF Health Shands Hospital (US), AdventHealth Orlando (US), University of Florida (US), Florida Urology Associates (US), Statistical Research (United States) (US), University of Oklahoma Health Sciences Center (US), Florida College (US)
HCA Healthcare
Openalex Percentile: Top 66%
Gastric Cancer Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.